Top Markets
Coin of the day
Alseres Pharmaceuticals, Inc. Alseres Pharmaceuticals, Inc.

Alseres Pharmaceuticals, Inc.

ALSE
Classement en actions #42806
Alseres Pharmaceuticals, Inc. focuses on creating both diagnostic and... Alseres Pharmaceuticals, Inc. focuses on creating both diagnostic and therapeutic solutions, with a primary emphasis on ailments affecting the central nervous system. Their flagship experimental compound is Altropane, a molecular imaging agent developed for identifying and diagnosing Parkinson's disease and dementia. Founded in 1972, the company was previously known as Boston Life Sciences, Inc. before officially changing its name to Alseres Pharmaceuticals, Inc. in June 2007. Its operations are headquartered in Auburndale, Massachusetts.
Prix de l'action
$0.01
Dernière synchronisation: 2024-08-19
Capitalisation boursière
$61.27
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Alseres Pharmaceuticals, Inc. (ALSE)

Catégorie

Le prix ALSE avec la capitalisation boursière de B
Alseres Pharmaceuticals, Inc. Alseres Pharmaceuticals, Inc.
ALSE
$0.01
Capitalisation boursière de Alseres Pharmaceuticals, Inc.(ALSE)
Capitalisation boursière: $61.27
En August 2026, Alseres Pharmaceuticals, Inc. a une capitalisation boursière de $61.27. Cela fait de Alseres Pharmaceuticals, Inc. la 42806th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Alseres Pharmaceuticals, Inc. du 1994 au 2026
ALSE par rapport au top 5 des plus populaires stocks
Prix pour ALSE L’actif B La capitalisation boursière de B Résultats
Alseres Pharmaceuticals, Inc. Alseres Pharmaceuticals, Inc.
$885,586,506 $61.27
$5.426T +8,855,865,061,892.82%
Alseres Pharmaceuticals, Inc. Alseres Pharmaceuticals, Inc.
$724,155,929 $61.27
$4.437T +7,241,559,285,096.67%
Alseres Pharmaceuticals, Inc. Alseres Pharmaceuticals, Inc.
$677,229,706 $61.27
$4.149T +6,772,297,057,779.88%
Alseres Pharmaceuticals, Inc. Alseres Pharmaceuticals, Inc.
$597,982,802 $61.27
$3.664T +5,979,828,016,057.99%
Alseres Pharmaceuticals, Inc. Alseres Pharmaceuticals, Inc.
$471,560,223 $61.27
$2.889T +4,715,602,234,272.45%